1. Kishkun A. A. Sovremennyie metody diagnostiki i ocenki effectivnosty lechenia infekcii, vyzvannoy Helicobacter pylori (obzor literatury) [Modern methods for diagnosing and evaluating the effectiveness of the treatment of Helicobacter pylori infection (literature review)]. Klinicheskaya laboratornaya diagnostika - Clinical Laboratory Diagnostics. 2002, no. 8, pp. 41-46. (In Russ.)@@ Kishkun A. A. Sovremennye metody diagnostiki i otsenki effektivnosti lecheniya infektsii, vyzvannoi Helicobacter pylori (Obzor literatury). Klinicheskaya laboratornaya diagnostika. 2002, № 8, C. 41-46.
2. Plavnik R. G., Bakulina N. V., Mareeva D. V., Bordin D. S. Epidemiologiya Helicobacter pylori: kliniko-laboratornie paralleli [Epidemiology of Helicobacter pylori: clinical and laboratory parallels]. Effektivnaya farmakoterapiya - Effective pharmacotherapy. 2019, vol. 15, no. 36, pp. 16-20. (In Russ.) https://doi.org/10.33978/2307-3586-2019-15-36-16-20@@ Plavnik R. G., Bakulina N. V., Mareeva D. V., Bordin D. S. Epidemiologiya Helicobacter pylori: kliniko-laboratornye paralleli. Effektivnaya farmakoterapiya. 2019, T. 15, № 36, S. 16-20. https://doi.org/10.33978/2307-3586-2019-15-36-16-20
3. Atherton J. C., Cao P., Peek R. M., et al. Mosaicium in vacuolatingcytotoxin alleles of Helicobacter pylori. Association of specific vac A types with cytotoxin production and peptic ulceration. J. Biol. Chem. 1995, no. 28, pp. 17771-17777.
4. Sinnett C. G., Letley D. P., Narayanan G. L., et al. Helicobacter pylori vac A transcription is genetically determined and stratifies the level of human gastric inflammation and atrothy. J. Clin. Pathol. 2016, no. 69, pp. 968-973.
5. Nukano M., Yahiro K., Yamasaki E. et al. Helicobacter pylori Vac A acting through receptor protein tyrosin phosphatase alpha is crucial for Cag A phosphorylation in human duodenum carcinoma cell line AZ.521. Dis. Model. Mech. 2016, no. 9, pp. 1473-1481.
6. Isaeva G.SH., Valieva R. I. Biologicheskie svojstva i virulentnost’ Helicobacter pylori. [Biological properties and virulence of Helicobacter pylori]. Ministry of Health of Russia Publ., Kazan, Russia. 2018, vol. 20, no. 1, pp. 14-20. (In Russ.)@@ Isaeva G. Sh., Valieva R. I. Biologicheskie svoistva i virulentnost' Helicobacter pylori. Minzdrav Rossii, Kazan', Rossiya. 2018. T. 20. № 1. S. 14-20.
7. Chernyavskij V. I., Biryukova S. V. et al. Helicobacter pylori-Herpesviridae assotsiatsii v ehtiopatogeneze neoplasticheskikh porazhenij zheludka, sovremennye aspekty izucheniya [Helicobacter pylori-Herpesviridae association in the etiopathogenesis of neoplastic lesions of the stomach, current aspects of the study]. Annaly Mechnikovskogo Instituta - Anali Mechnikovsky Institute. 2005, no. 1, pp. 48-62. (In Russ.)@@ Chernyavskii V. I., Biryukova S. V. i dr. Helicobacter pylori-Herpesviridae assotsiatsii v etiopatogeneze neoplasticheskikh porazhenii zheludka, sovremennye aspekty izucheniya. Annaly Mechnikovskogo Instituta. 2005, № 1, S. 48-62.
8. Novikov V. V., Lapin V. A., Melentiev D. A. I dr. Osobennosty immunnogo otveta na inficirovaniye Helicobacter pylori [Features of the human immune response to Helicobacter pylori infection]. Medial Publ. 2019, vol. 24, no. 2, pp. 55-69. (In Russ.)@@ Novikov V. V., Lapin V. A., Melent'ev D. A. i dr. Osobennosti immunnogo otveta cheloveka na infitsirovanie Helicobacter pylori. Medial'. 2019, № 2 (24), S. 55-69.
9. Jafarzadeh A., Esmaeeli-Nadimi A., Nemati M., et al. Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischemic heart disease. East. Mediterr. Health J. 2010, vol. 16, no. 10, pp. 1039-1044.
10. Niccoli G., Franceschi F., Cosentino N., et al. Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron. Artery Dis. 2010, vol. 21, no. 4, pp. 217-221.
11. Pavlov O. N. Svyaz infekcii Helicobacter pylori i systemnogo vospaleniya u bolnych s nestabylnym techeniem ishemycheskoy bolezny serdca [The relationship of Helicobacter pylori infection and systemic inflammation in patients with unstable coronary heart disease]. Prakticheskaya medicina - Practical medicine. 2012, vol. 58, no. 3, pp. 49-52. (In Russ.)@@ Pavlov O. N. Svyaz' infektsii Helicobacter pylori i sistemnogo vospaleniya u bol'nykh s nestabil'nym techeniem ishemicheskoi bolezni serdtsa. Prakticheskaya meditsina. 2012, № 3 (58), S. 49-52.
12. Prikhodko M. N., Andreev K. V., Simonov Zh. G. Osobennosti sostoyaniya obshchih sonnyh arterij u bol’nyh stabil’noj stenokardiej pri sochetanii s gastroduodenal’noj patologiej [Features of the state of common carotid arteries in patients with stable angina pectoris when combined with gastroduodenal pathology]. Vyatskij medicinskij vestnik - Vyatka medical bulletin. 2017, vol. 55, no. 3, pp. 15-19. (In Russ.)@@ Prikhod'ko M. N., Andreev K. V., Simonova Zh. G. Osobennosti sostoyaniya obshchikh sonnykh arterii u bol'nykh stabil'noi stenokardiei pri sochetanii s gastroduodenal'noi patologiei. Vyatskii meditsinskii vestnik. 2017, № 3 (55), S. 15-19.
13. Symonova Zh. G., Martusevich A. K., Tarlovskaya E. I. Analyz rlinicheskoy effectivnosty eradikacionnoy terapii u bolnych ishemycheskoy bolezniyu serdca, associirovannoy s patologiey gastroduodenalnoi zony [Analysis of the clinical efficacy of eradication therapy in patients with coronary heart disease associated with gastroduodenal pathology]. Terapevticheskij arhiv - Therapeutic Archive. 2017, vol. 89, no. 8, pp. 37-42. (In Russ.)@@ Simonova Zh. G., Martusevich A. K., Tarlovskaya E. I. Analiz klinicheskoi effektivnosti eradikatsionnoi terapii u bol'nykh ishemicheskoi bolezn'yu serdtsa, assotsiirovannoi s patologiei gastroduodenal'noi zony. Terapevticheskii arkhiv. 2017, № 8 (89), S. 37-42.
14. Prikhodko M. N., Prikhodko L. O., Kolevatykh E. P., Ikonnikov S. V., Simonov Z. G. Assessment of the antibiotic susceptibility of helicobacter pylori in patients with stable angina with concomitant gastroduodenal pathology. Experimental and Clinical Gastroenterology. 2018;(3):34-40. (In Russ.)@@ Prikhod'ko M. N., Prikhod'ko L. O., Kolevatykh E. P., Ikonnikov S. V., Simonova Zh. G. Otsenka antibiotikochuvstvitel'nosti Helicobacter pylori u bol'nykh stabil'noi stenokardiei s soputstvuyushchei gastroduodenal'noi patologiei. Eksperimental'naya i klinicheskaya gastroenterologiya. 2018, T. 151, № 3, S. 34-40.
15. Lerner A., Arleevskaya M., Schmiedl A. et al. Microbes and viruses are bugging the gut in celiac disease. Are they friends or foes? Front. Microbiol. 2017, vol. 8, pp. 1392.
16. Rittig M. G., Shaw. B., Letley D. P. et al. Helicobacter pylori-induced homotypic phagosome fusion in human monocytes is independent of the bacterial vacA and cag status. Cell. Microbiol. 2003, vol. 5, pp. 887-899.
17. Berezniyak E. A., Sorokina V. M., Karpova I. O. Osobennosty genotypov shtammov Helicobacter pylori, circuliruishich v Rostovskoy oblasty [Features of the genotypes of Helicobacter pylori strains circulating in the Rostov region]. Epidemiologiya - Epidemiology. 2013, vol. 71, no. 4, pp. 30-33. (in Russ.)@@ Bereznyak E. A., Sorokin V. M., Karpova I. O. Osobennosti genotipov shtammov Helicobacter pylori, tsirkuliruyushchikh v Rostovskoi oblasti. Epidemiologiya. 2013, № 4 (71), S. 30-33.